For weight management, treatment typically requires at least 612 months, with NICE recommending discontinuation if less than 5% weight loss is achieved after 6 months (Wegovy) or 12 weeks (Saxenda) at maintenance doses
It amplifies the bodys natural youre full messages and quiets signals that drive appetite
Other studies relevant to psychiatric adverse outcomes are in Supplementary Information
To support digestive comfort, focus on small, slower meals
Evidence-based management varies substantially depending on the specific autoimmune disorder, disease severity, organ involvement, and individual patient factors
During this 'sweet spot' window, you'll experience maximum appetite suppression and sustained lower food intake without white-knuckling hunger